Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/139917/1/sim7430.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/139917/2/sim7430_am.pd
The validation of surrogate endpoints has been studied by Prentice, who presented a definition as we...
The last 20 years have seen lots of work in the area of surrogate marker validation, partly devoted ...
At the beginning of the 21st century, a new paradigm was introduced for the evaluation of surrogate ...
Two paradigms for the evaluation of surrogate markers in randomized clinical trials have been propos...
In this paper, we show that Prentice's criteria for surrogates can be strengthened to remedy so...
Nowadays, two main frameworks for the evaluation of surrogate endpoints, based on causal-inference a...
The relationship between association and surrogacy has been the focus of much debate in the surrogat...
A surrogate marker ( S ) is a variable that can be measured earlier and often more easily than the t...
Most methods for evaluating surrogate endpoints measure validity in terms of net effects (i.e., trea...
In this work a new metric of surrogacy, the so-called individual causal association (ICA), is introd...
Several methods have been developed for the evaluation of surrogate endpoints within the causal-infe...
The individual causal association (ICA) has recently been introduced as a metric of surrogacy in a c...
Randomized clinical trials with rare primary endpoints or long duration times are costly. Because of...
BACKGROUND: A surrogate marker is a variable commonly used in clinical trials to guide treatment dec...
Frangakis and Rubin (2002, Biometrics 58, 21–29) proposed a new definition of a surrogate endpoint (...
The validation of surrogate endpoints has been studied by Prentice, who presented a definition as we...
The last 20 years have seen lots of work in the area of surrogate marker validation, partly devoted ...
At the beginning of the 21st century, a new paradigm was introduced for the evaluation of surrogate ...
Two paradigms for the evaluation of surrogate markers in randomized clinical trials have been propos...
In this paper, we show that Prentice's criteria for surrogates can be strengthened to remedy so...
Nowadays, two main frameworks for the evaluation of surrogate endpoints, based on causal-inference a...
The relationship between association and surrogacy has been the focus of much debate in the surrogat...
A surrogate marker ( S ) is a variable that can be measured earlier and often more easily than the t...
Most methods for evaluating surrogate endpoints measure validity in terms of net effects (i.e., trea...
In this work a new metric of surrogacy, the so-called individual causal association (ICA), is introd...
Several methods have been developed for the evaluation of surrogate endpoints within the causal-infe...
The individual causal association (ICA) has recently been introduced as a metric of surrogacy in a c...
Randomized clinical trials with rare primary endpoints or long duration times are costly. Because of...
BACKGROUND: A surrogate marker is a variable commonly used in clinical trials to guide treatment dec...
Frangakis and Rubin (2002, Biometrics 58, 21–29) proposed a new definition of a surrogate endpoint (...
The validation of surrogate endpoints has been studied by Prentice, who presented a definition as we...
The last 20 years have seen lots of work in the area of surrogate marker validation, partly devoted ...
At the beginning of the 21st century, a new paradigm was introduced for the evaluation of surrogate ...
DOI
Add to ORKG